AGGRESSIVE VARIANT PROSTATE CARCINOMA
Clinical trials for AGGRESSIVE VARIANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE VARIANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE VARIANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on tough, spreading cancers
Disease control OngoingThis early-stage study is testing a new combination of two drugs, DS3201 and ipilimumab, for people with advanced prostate, bladder, or kidney cancer that has spread. The main goals are to find the safest dose and understand the side effects. Researchers hope the drug combo will …
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo aims to tame deadly prostate cancer
Disease control OngoingThis study is testing a multi-step treatment to control a fast-spreading and hard-to-treat form of prostate cancer. It will involve about 120 men whose cancer has spread and is resistant to standard hormone therapy. The goal is to see if combining chemotherapy, a drug that helps …
Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC